Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Cisplatin and Etoposide Plus BKM120 in Advanced Solid Tumors, With an Emphasis on Small Cell Lung Cancer

NCT02194049 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT02194049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02194049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Cisplatin and Etoposide Plus BKM120 in Advanced Solid Tumors, With an Emphasis on Small Cell Lung Cancer
Lead sponsor
University of California, Davis
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2014
Completion date
June 30, 2016
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extensive stage small cell lung cancer, unspecified adult solid tumor, protocol specific